Stock Events

Stock Events

Glenmark Pharmaceuticals (GLENMARK.NSE) Q3 2025 Earnings

13AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

1.69

6.07

10.44

14.82

Details

Expected EPS

13.158231766560002

Actual EPS

1.693229824224

Surprise EPS

-11.47

Surprise Percent

+87.13%

Description

Glenmark Pharmaceuticals (GLENMARK.NSE) has reported earnings of 1.693229824224 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.